FDA relations during drug development

Article Properties
Cite
Mitchel, Jules T. “FDA Relations During Drug Development”. Dialogues in Clinical Neuroscience, vol. 2, no. 3, 2000, pp. 213-7, https://doi.org/10.31887/dcns.2000.2.3/jtmitchel.
Mitchel, J. T. (2000). FDA relations during drug development. Dialogues in Clinical Neuroscience, 2(3), 213-217. https://doi.org/10.31887/dcns.2000.2.3/jtmitchel
Mitchel JT. FDA relations during drug development. Dialogues in Clinical Neuroscience. 2000;2(3):213-7.
Journal Category
Medicine
Internal medicine
Neurosciences
Biological psychiatry
Neuropsychiatry
You May Also Like
Refrences
Title Journal Journal Categories Citations Publication Date
Title
National Archives and Records Administration. Office of the Federal Register, Washington, DC. Available at: http://www.nara.gov/fedreg/. Accessed 14 September 2000.
Freedom of Information Reading Room. Food and Drug Administration, Rockville, Md. Available at: http://www.fda.gov/foi/foia2.htm. Accessed 14 September 2000.
Federal Food, Drug, and Cosmetic Act as amended by the Food and Drug Administration Modernization Act of 1997, Public Law 105-115, 105th Congress, Washington, DC.
Assignment of Agency Component for Review of Premarket Applications, Final rule. 21 CFR Part 3 [Docket No 91N-0257], 56 Federal Register (FR) 58754, Dept of Health And Human Services, Food and Drug Administration, 21 November 1991. Available at: http://www.fda.gov/cder/guidance/105-115.htm.Accessed 14 September 2000.